Microbiología clínica y enfermedades Infecciosas

Ramos-Martinez, A; Pintos-Pascual, I; Guinea, J; Gutierrez-Villanueva, A; Gutierrez-Abreu, E; Diaz-Garcia, J; Asensio, A; Iranzo, R; Sanchez-Romero, I; Munoz-Algarra, M; Moreno-Torres, V; Calderon-Parra, J; Munez, E; Fernandez-Cruz, A.

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis

Journal of Fungi. 2022; 8(5): Nº de citas: 38 [doi:10.3390/jof8050451]

Garcia-Alvarez, L; Garcia-Garcia, C; Munoz, P; Farinas-Alvarez, MD; Cuadra, MG; Fernandez-Hidalgo, N; Garcia-Vazquez, E; Moral-Escudero, E; Alonso-Socas, MD; Garcia-Rosado, D; Hidalgo-Tenorio, C; Dominguez, F; Goikoetxea-Agirre, J; Gainzarain, JC; Rodriguez-Esteban, MA; Bosch-Guerra, X; Oteo, JA.

Bartonella Endocarditis in Spain: Case Reports of 21 Cases

Pathogens. 2022; 11(5): Nº de citas: 22 [doi:10.3390/pathogens11050561]

Jbara, S; Herranz, M; Sola-Campoy, PJ; Rodriguez-Grande, C; Chiner-Oms, A; Comas, I; Munoz, P; de Viedma, DG; Perez-Lago, L.

Overlapping prison/community tuberculosis outbreaks in Costa Rica revealed by alternative analysis of suboptimal material

TRANSBOUNDARY AND EMERGING DISEASES. 2022; 69(3): 1065-1072 [doi:10.1111/tbed.14063]

Campoy PJS; Buenestado-Serrano S; Pérez-Lago L; Rodriguez-Grande C; Catalán P; Andrés-Zayas C; Alcalá L; Losada C; Rico-Luna C; Muñoz P; de Viedma DG.

First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(5): 262-265 Nº de citas: 5 [doi:10.1016/j.eimc.2021.05.008]

Guembe, MG; Pensado, YT; Picado, FT; Diez, C; Latorre, LP; Fanciulli, C; Vazquez, FP; de Quiros, JCLB; Berenguer, J; Ortega, BP; Machado, M; Minero, MV; Garcia, PM; Santiago, EB; Galar, A; Catalan, P; Alonso, R; Bellon, JM; Lois, TAE; Gregorio Maranon Microbiology-ID.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid

AIDS RESEARCH AND HUMAN RETROVIRUSES. 2022; 38(5): 394-398 Nº de citas: 4 [doi:10.1089/aid.2021.0159]

Caston, JJ; Cano, A; Perez-Camacho, I; Aguado, JM; Carratala, J; Ramasco, F; Soriano, A; Pintado, V; Castelo-Corral, L; Sousa, A; Farinas, MC; Munoz, P; De Medrano, VAL; Sanz-Pelaez, O; Los-Arcos, I; Gracia-Ahufinger, I; Perez-Nadales, E; Vidal, E; Doblas, A; Natera, C; Martinez-Martinez, L; Torre-Cisneros, J.

Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(5): 1452-1460 Nº de citas: 59 [doi:10.1093/jac/dkac049]

Zvezdanova, ME; Escribano, P; Guinea, J; Munoz, P; Rodriguez-Temporal, D; Rodriguez-Sanchez, B.

Evaluation of the Vitek Ms system for the identification of filamentous fungi

MEDICAL MYCOLOGY. 2022; 60(4): Nº de citas: 10 [doi:10.1093/mmy/myac027]

Carrera-Salinas A; González-Díaz A; Vázquez-Sánchez DA; Camoez M; Niubó J; Càmara J; Ardanuy C; Martí S; Domínguez MÁ.

Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones

RESEARCH IN MICROBIOLOGY. 2022; 173(3): 103921-103921 Nº de citas: 9 [doi:10.1016/j.resmic.2022.103921]

Burillo, A; Candel, FJ; Canut-Blasco, A.

Value of syndromic panels in the management of severe community-acquired pneumonia

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35: 15-20 Nº de citas: 3

Bouza, E; Burillo, A.

Current international and national guidelines for managing skin and soft tissue infections

CURRENT OPINION IN INFECTIOUS DISEASES. 2022; 35(2): 61-71 Nº de citas: 25 [doi:10.1097/QCO.0000000000000814]

Bouza E; Arribas JR; Alejos B; Bernardino JI; Coiras M; Coll P; Del Romero J; Fuster MJ; Górgolas M; Gutiérrez A; Gracia D; Hernando V; Martínez-Picado J; Martínez Sesmero JM; Martínez E; Moreno S; Mothe B; Navarro ML; Podzamczer D; Pulido F; Ramos JT; Ruiz-Mateos E; Suárez García I; Palomo E.

Past and future of HIV infection. A document based on expert opinion

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(2): 131-156 Nº de citas: 7 [doi:10.37201/req/083.2021]

Sivori, F; Cavallo, I; Kovacs, D; Guembe, M; Sperduti, I; Truglio, M; Pasqua, M; Prignano, G; Mastrofrancesco, A; Toma, L; Pimpinelli, F; Morrone, A; Ensoli, F; Di Domenico, EG.

Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections

Microbiology Spectrum. 2022; 10(2): Nº de citas: 31 [doi:10.1128/spectrum.00351-22]

Fresco-Taboada, A; Garcia-Duran, M; Aira, C; Lopez, L; Sastre, P; van der Hoek, L; van Gils, MJ; Brouwer, PJM; Sanders, RW; Holzer, B; Zimpernikc, I; Lopez-Collazo, E; Munoz, P; Rueda, P; Vela, C.

Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2022; 102(4): Nº de citas: 4 [doi:10.1016/j.diagmicrobio.2022.115650]

Prattes, J; Wauters, J; Giacobbe, DR; Salmanton-Garcia, J; Maertens, J; Bourgeois, M; Reynders, M; Rutsaert, L; Van Regenmortel, N; Lormans, P; Feys, S; Reisinger, AC; Cornely, OA; Lahmer, T; Valerio, M; Delhaes, L; Jabeen, K; Steinmann, J; Chamula, M; Bassetti, M; Hatzl, S; Rautemaa-Richardson, R; Koehler, P; Lagrou, K; Hoenigl, M.

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

CLINICAL MICROBIOLOGY AND INFECTION. 2022; 28(4): 580-587 Nº de citas: 185 [doi:10.1016/j.cmi.2021.08.014]

Calero, AL; Alonso, R; Gadea, I; Vega, MDM; Garcia, MM; Munoz, P; Machado, M; Bouza, E; Garcia-Rodriguez, J.

Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest

Microbiology Spectrum. 2022; 10(2): Nº de citas: 28 [doi:10.1128/spectrum.02626-21]

Varona, JF; Landete, P; Lopez-Martin, JA; Estrada, V; Paredes, R; Guisado-Vasco, P; de Orueta, LF; Torralba, M; Fortun, J; Vates, R; Barberan, J; Clotet, B; Ancochea, J; Carnevali, D; Cabello, N; Porras, L; Gijon, P; Monereo, A; Abad, D; Zuniga, S; Sola, I; Rodon, J; Vergara-Alert, J; Izquierdo-Useros, N; Fudio, S; Pontes, MJ; de Rivas, B; de Velasco, PG; Nieto, A; Gomez, J; Aviles, P; Lubomirov, R; Belgrano, A; Sopesen, B; White, KM; Rosales, R; Yildiz, S; Reuschl, AK; Thorne, LG; Jolly, C; Towers, GJ; Zuliani-Alvarez, L; Bouhaddou, M; Obernier, K; McGovern, BL; Rodriguez, ML; Enjuanes, L; Fernandez-Sousa, JM; Krogan, NJ; Jimeno, JM; Garcia-Sastre, A.

Preclinical and randomized phase I studies of plitidepsin in adults with COVID-19

Life Science Alliance. 2022; 5(4): Nº de citas: 35 [doi:10.26508/lsa.202101200]

García-Lledó A; Gómez-Pavón J; González Del Castillo J; Hernández-Sampelayo T; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; García-Botella A; Bouza E.

Pharmacological treatment of COVID-19: an opinion paper

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(2): 115-130 Nº de citas: 41 [doi:10.37201/req/158.2021]

García-Botella A; García-Lledó A; Gómez-Pavón J; González Del Castillo J; Hernández-Sampelayo T; Martín-Delgado MC; Martín Sánchez FJ; Martínez-Sellés M; Molero García JM; Moreno Guillén S; Rodríguez-Artalejo FJ; Ruiz-Galiana J; Cantón R; De Lucas Ramos P; Bouza E.

Booster or additional vaccination doses in patients vaccinated against COVID-19

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(2): 105-114 Nº de citas: 6 [doi:10.37201/req/149.2021]